Vallon Pharmaceuticals is Pharmaceuticals in United States that focus on Vallon Pharmaceuticals Inc business. Founded in 2018. They cover business area such as Vallon Pharmaceuticals Inc, commercialization, proprietary biopharmaceutical product, prescription drug, central nervous system disorder, its product ADAIR, immediate-release dextroamphetamine, attention-deficit/hyperactivity disorder.
2018
( 6 years old in 2024 )
Vallon Pharmaceuticals Inc
-
Two Logan Square, 100 North 18th Street
Suite 300
Philadelphia, PA 19103
United States
Private
Vallon Pharmaceuticals Inccommercializationproprietary biopharmaceutical productprescription drugcentral nervous system disorderits product ADAIRimmediate-release dextroamphetamineattention-deficit/hyperactivity disorder
* We use standard office opening hours in near Vallon Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Vallon Pharmaceuticals is Pharmaceuticals business from United States that founded in 2018 (6 years old in 2024), Vallon Pharmaceuticals business is focusing on Vallon Pharmaceuticals Inc.
Vallon Pharmaceuticals headquarter office and corporate office address is located in Two Logan Square, 100 North 18th Street Suite 300 Philadelphia, PA 19103 United States.
Vallon Pharmaceuticals was founded in United States.
In 2024, Vallon Pharmaceuticals is currently focus on Vallon Pharmaceuticals Inc sector.
Above is snippet of Google Trends for "Vallon Pharmaceuticals Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Vallon Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
